Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Alcoa Chief Operations Officer Sells 4,600 Shares at $46.82 as Insider Trading Activity Disclosed

Matthew T. Reed, Executive Vice President and Chief Operations Officer of Alcoa Corporation, sold 4,600 shares of common stock on July 22, 2026, at $46.82 per share, according to an insider transaction report filed with the Securities and Exchange Commission. The transaction reduced Reed's …

Aakashdeep | 23 July 2026

Jefferies Financial Group Issues Senior Autocallable Notes Linked to Three Major Stock Indices

Jefferies Financial Group Inc. has announced a preliminary pricing for Senior Autocallable Contingent Coupon Barrier Notes due August 16, 2032, according to a disclosure filed July 23, 2026. The notes, which are linked to the worst-performing of three major indices—the Dow Jones Industrial Average, …

Manish Choudhary | 23 July 2026

United Therapeutics Director Christopher Patusky Receives Stock Options and Common Stock Award

United Therapeutics Corporation announced that Christopher Patusky, a director at the biopharmaceutical company, received equity compensation on July 22, 2026, consisting of stock options and common shares. The transaction, disclosed through a regulatory update filed July 23, 2026, reflects routine annual non-employee director compensation …

Aakashdeep | 23 July 2026

United Therapeutics Director Christopher Causey Receives Stock Options and Common Stock Award

United Therapeutics Corporation disclosed that Christopher Causey, a director of the biopharmaceutical company, received equity compensation consisting of stock options and common stock as part of an annual non-employee director award on July 22, 2026. The transaction, reported on July 23, 2026, reflects routine …

Aakashdeep | 23 July 2026

United Therapeutics Director Louis Sullivan Corrects Stock Holdings and Receives Annual Option Grant

United Therapeutics Corporation disclosed an ownership update on July 23, 2026, revealing that director Louis W. Sullivan corrected a prior reporting error related to his beneficial stock holdings. The update reflects a clerical mistake in a previous disclosure and includes the grant of stock …

Anjali Anand | 23 July 2026

Bank of Montreal Issues $993,000 Autocallable Notes Linked to IBM Stock With Quarterly Contingent Coupons

Bank of Montreal completed a pricing and distribution of Senior Medium-Term Notes, Series K on July 21, 2026, comprising $993,000 in principal amount of autocallable barrier notes linked to International Business Machines Corporation common stock. The notes feature a contingent quarterly coupon rate of …

Nitish Kishor | 23 July 2026

Morgan Stanley Finance Launches Structured Securities Linked to NVIDIA and Broadcom with 20% Contingent Return and Full Downside Risk

Morgan Stanley Finance LLC has issued $1.206 million in market-linked securities tied to the performance of NVIDIA Corporation and Broadcom Inc., maturing August 2, 2027. The securities offer investors a fixed 20% return if the lowest-performing stock remains above 60% of its starting price, …

Aakashdeep | 23 July 2026

Franklin Resources Executive Nicholls Acquires 229,850 Shares in Insider Stock Transaction

Franklin Resources Inc. (NYSE: BEN) reported that Matthew Nicholls, the company's Co-President, Chief Financial Officer, and Chief Operating Officer, acquired 229,850 shares of common stock on July 21, 2026, at $32.63 per share. The transaction reflects significant insider investment in the global asset management …

Shwetambri Chauhan | 23 July 2026

Franklin Resources Co-President Terrence Murphy Acquires Nearly 230,000 Shares in Stock Purchase

Terrence Murphy, Co-President of Public Markets at Franklin Resources Inc., acquired 229,850 shares of the company's common stock on July 21, 2026, at a price of $32.63 per share. The transaction, disclosed in a regulatory update filed on July 23, 2026, brings Murphy's total …

Nitish Kishor | 23 July 2026

Vertex Pharmaceuticals Executive Amit Sachdev Acquires Over 8,250 Company Shares Through Restricted Stock Award

Amit Sachdev, Executive Vice President of Chief Patient and External Affairs at Vertex Pharmaceuticals Inc., acquired 8,251 shares of company common stock on July 21, 2026, according to a disclosure filed July 23, 2026. The acquisition occurred through a restricted stock unit award that …

Aditi Sarkar | 23 July 2026
Support

Hi! How can we help you today?

Loading…